Trial intelligence / Profile preview

PARACHUTES: Pedophilia At Risk – Acute Treatment – E-therapy vs SSRI

2024-513388-16-00Phase 2Authorised

Sponsor
Karolinska University Hospital
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of fluoxetine in pedophilic disorder and Hebephilia (2 arms), sponsored by Karolinska University Hospital. Planned start Jun 2024; status: authorised.

02

Drugs

fluoxetine
03

Conditions

pedophilic disorderHebephilia

Beyond the preview

Go deeper on 2024-513388-16-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-513388-16-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call